Showing results (1781-1790 of 1,800) with videos related to
Sort By:
Pageof 180
Mabs|June 20, 2023
Efficient production of bispecific antibody by FAST-IgTM and its application to NXT007 for the treatment of hemophilia AHikaru Koga, Takashi Yamano, Juan Betancur, et al.Mabs|June 25, 2026
Discovery and optimization of a pH-responsive ultra-long-acting VHH-based growth hormone mimeticHoucong Jin, Gao Sun, Hongxia Shen, et al.Mabs|April 8, 2017
Identification of human IgG1 variant with enhanced FcRn binding and without increased binding to rheumatoid factor autoantibodyAtsuhiko Maeda, Yuki Iwayanagi, Kenta Haraya, et al.Mabs|December 20, 2014
Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-lifeRanajoy Majumdar, Reza Esfandiary, Steven M Bishop, et al.Mabs|May 30, 2014
ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody ⁸⁹Zr-RG7116Anton G T Terwisscha van Scheltinga, Marjolijn N Lub-de Hooge, Keelara Abiraj, et al.Mabs|June 19, 2026
Development of single-chain C1q affinity chromatography-mass spectrometry for the glycoform-resolved characterization of low-affinity immunoglobulin G interactionsSteffen Lippold, Kelvin Chang, Mirjam Dürkoop, et al.Mabs|April 2, 2026
Glycan pairing in therapeutic IgG orchestrates Fcγ receptor engagement and ADCC: an integrated structure-function approach for thorough evaluation of Fc N-glycans as critical quality attributesMaximilian Meudt, Julia Baumeister, Antoinette Cassiopeia Russell, et al.Mabs|April 30, 2026
Population-level analysis of glycoprotein glycoformsAlejandro Gomez Toledo, James T Sorrentino, Sanne Schoffelen, et al.Mabs|March 25, 2026
Hybrid AI/ML-mechanistic framework enables intelligent optimization of commercial biopharmaceutical downstream processingRong-Zhu Wang, Yu-Xin Liao, Teng-Long Wang, et al.Pageof 180